PANRETIN Drug Patent Profile
✉ Email this page to a colleague
When do Panretin patents expire, and what generic alternatives are available?
Panretin is a drug marketed by Concordia and is included in one NDA.
The generic ingredient in PANRETIN is alitretinoin. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the alitretinoin profile page.
Summary for PANRETIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 60 |
Patent Applications: | 4,985 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for PANRETIN |
What excipients (inactive ingredients) are in PANRETIN? | PANRETIN excipients list |
DailyMed Link: | PANRETIN at DailyMed |
Pharmacology for PANRETIN
Drug Class | Retinoid |
Anatomical Therapeutic Chemical (ATC) Classes for PANRETIN
US Patents and Regulatory Information for PANRETIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Concordia | PANRETIN | alitretinoin | GEL;TOPICAL | 020886-001 | Feb 2, 1999 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PANRETIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Concordia | PANRETIN | alitretinoin | GEL;TOPICAL | 020886-001 | Feb 2, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Concordia | PANRETIN | alitretinoin | GEL;TOPICAL | 020886-001 | Feb 2, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
EU/EMA Drug Approvals for PANRETIN
Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
---|---|---|---|---|---|---|---|---|---|
Eisai GmbH | Panretin | alitretinoin | EMEA/H/C/000279 Panretin gel is indicated for the topical treatment of cutaneous lesions in patients with acquired-immune-deficiency-syndrome (AIDS)-related Kaposi's sarcoma (KS) when:lesions are not ulcerated or lymphoedematous, and;treatment of visceral KS is not required, and;lesions are not responding to systemic antiretroviral therapy, and;radiotherapy or chemotherapy are not appropriate. |
Withdrawn | no | no | no | 2000-10-11 | |
>Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
International Patents for PANRETIN
See the table below for patents covering PANRETIN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 4001618 | ⤷ Try a Trial | |
Japan | 2007254481 | MEANS FOR MODULATING PROCESS MEDIATED BY RETINOID RECEPTOR AND COMPOUND USEFUL THEREFOR | ⤷ Try a Trial |
Japan | H08502238 | ⤷ Try a Trial | |
Netherlands | 300043 | ⤷ Try a Trial | |
Canada | 2123223 | MOYENS POUR LA MODULATION DE PROCEDES MEDIES PAR LES RECEPTEURS AUX RETINOIDES ET COMPOSES (MEANS FOR THE MODULATION OF PROCESSES MEDIATED BY RETINOID RECEPTORS AND COMPOUNDS USEFUL THEREFOR) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for PANRETIN
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0617614 | 11/2001 | Austria | ⤷ Try a Trial | PRODUCT NAME: ALITRETINOIN; REGISTRATION NO/DATE: EU/1/00/149/001 20001011 |
0617614 | CA 2001 00012 | Denmark | ⤷ Try a Trial | |
0617614 | C300043 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: ALITRETINOIN; NAT. REGISTRATION NO/DATE: EU/1/00/149/001 20001011; FIRST REGISTRATION: EU/1/00/149/001 20001011 |
0617614 | 2001/009 | Ireland | ⤷ Try a Trial | PRODUCT NAME: PANRETIN-ALITRETINOIN |
0617614 | SPC/GB01/014 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: ALITRETINOIN; REGISTERED: UK EU/1/00/149/001 20001018 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |